资讯
13 小时之前
引进/卖出
13 小时之前
Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR)
临床结果上市批准
13 小时之前
并购
13 小时之前
NeuroGenesis Bio Receives FDA Clearance to Proceed with Expanded Access Program for NG01 in Progressive Multiple Sclerosis
细胞疗法临床结果
20 小时之前
Carnyx Therapeutics Unveils Oral Sleep Candidate CNYX-005 with Preclinical Data Showing Increased NREM Sleep
临床结果
22 小时之前
融资
22 小时之前
TRYNGOLZA™ (olezarsen) approved in the EU for severe hypertriglyceridemia (sHTG)
上市批准引进/卖出
22 小时之前
并购引进/卖出
22 小时之前
Acadia Pharmaceuticals Presents Additional Phase 2 RADIANT Study Results Evaluating Remlifanserin for the Treatment of Alzheimer’s Disease Psychosis at the 2026 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
临床结果
Zealand Pharma announces EU approval of Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome
临床结果上市批准孤儿药